Viral conjunctivitis
diseaseOn this page
Also known as Conjunctivitides, viralviral ConjunctivitidesViruses caused conjunctivitis (disease)Viruses conjunctivitis (disease)
Summary
Viral conjunctivitis (MONDO:0043541) is a disease and 10 clinical trials. Top therapeutic interventions include dexamethasone. A subtype of conjunctivitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Clinical trials: 10
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | viral conjunctivitis |
| Mondo ID | MONDO:0043541 |
| EFO | EFO:0008571 |
| MeSH | D003236 |
| ICD-10-CM | B30 |
| ICD-11 | 157616931 |
| NCIT | C34509 |
| SNOMED CT | 45261009 |
| UMLS | C0009774 |
| MedGen | 3212 |
| Is cancer (heuristic) | no |
Also known as: Conjunctivitides, viral · viral Conjunctivitides · viral conjunctivitis · Viruses caused conjunctivitis (disease) · Viruses conjunctivitis (disease)
Disease family
This is a subtype of conjunctivitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › disorder of orbital region › eye adnexa disorder › conjunctival disorder › conjunctivitis › viral conjunctivitis
Related subtypes (7): acute conjunctivitis, blepharoconjunctivitis, papillary conjunctivitis, chronic conjunctivitis, keratoconjunctivitis, rosacea conjunctivitis, bacterial conjunctivitis
Subtypes (2): epidemic keratoconjunctivitis, acute hemorrhagic conjunctivitis
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
Drugs indicated for this disease
0 approved, 2 in late-stage (phase 3) trials. Disease-direct ChEMBL indications, not inferred from the associated-gene cohort below.
| Drug | Development status |
|---|---|
| Dexamethasone | Phase 3 (in late-stage trials) |
| Povidone-Iodine | Phase 3 (in late-stage trials) |
Earlier-phase candidates (phase 2, investigational — efficacy not yet established): Carboxymethylcellulose Sodium, Ketorolac.
Clinical trials & evidence
Clinical trials
Clinical trials: 10.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 6 |
| PHASE2 | 2 |
| PHASE4 | 1 |
| PHASE3 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT01179412 | PHASE4 | COMPLETED | Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine |
| NCT01481519 | PHASE3 | COMPLETED | A Trial of Topical Dexamethasone Versus Artificial Tears for Treatment of Viral Conjunctivitis |
| NCT01461954 | PHASE2 | COMPLETED | FST-100 in the Treatment of Acute Viral Conjunctivitis |
| NCT01977443 | PHASE2 | COMPLETED | Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC) |
| NCT02054234 | Not specified | COMPLETED | ADenoVirus Initiative Study in Epidemiology in France |
| NCT02054273 | Not specified | COMPLETED | ADenoVirus Initiative Study in Epidemiology in Germany |
| NCT02112773 | Not specified | COMPLETED | ADenoVirus Initiative Study in Epidemiology in UK |
| NCT02254330 | Not specified | COMPLETED | ADenoVirus Initiative Study in Epidemiology in Spain |
| NCT03055065 | Not specified | COMPLETED | ADenoVirus Initiative Study in Epidemiology in Italy |
| NCT03861728 | Not specified | TERMINATED | Viral Conjunctivitis Treatment Study |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| DEXAMETHASONE | 4 | 1 |
Related Atlas pages
- Drugs: Dexamethasone